The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conti, L.
Right arrow Articles by Gessani, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conti, L.
Right arrow Articles by Gessani, S.
The Journal of Immunology, 00, 165: 3293-3300.
Copyright © 00 by The American Association of Immunologists

Dual Role of the HIV-1 Vpr Protein in the Modulation of the Apoptotic Response of T Cells1

Lucia Conti*, Paola Matarrese{dagger}, Barbara Varano*, Maria Cristina Gauzzi*, Akihiko Sato{ddagger}, Walter Malorni{dagger}, Filippo Belardelli* and Sandra Gessani2,*

Laboratories of * Virology and {dagger} Ultrastructures, Istituto Superiore di Sanità, Rome, Italy; and {ddagger} Shionogi Institute for Medical Science, Osaka, Japan

We investigated the effect of vpr, physiologically expressed during the course of an acute HIV-1 infection, on the response of infected cells to apoptotic stimuli as well as on the HIV-induced apoptosis. At 48 h after infection, Jurkat cells exhibited a lower susceptibility to undergo apoptosis with respect to uninfected cells. This effect was not observed following infection with either a vpr-mutated virus or a wild-type strain in the presence of antisense oligodeoxynucleotides targeted at vpr mRNA. Single-cell analysis, aimed at simultaneously identifying apoptotic and infected cells, revealed that resistance to apoptosis correlated with productive infection. Notably, vpr-dependent protection from induced apoptosis was also observed in HIV-1-infected PBMC. In contrast, at later stages of infection, a marked increase in the number of cells spontaneously undergoing apoptosis was detected in infected cultures. This virus-induced apoptosis involved vpr expression and predominantly occurred in productively infected cells. These results indicate that HIV-1 vpr can exert opposite roles in the regulation of apoptosis, which may depend on the level of its intracellular expression at different stages of HIV-1 infection. The dual function of vpr represents a novel mechanism in the complex strategy evolved by HIV to influence the turnover of T lymphocytes leading to either viral persistence or virus release and spreading.




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
B. Romani and S. Engelbrecht
Human immunodeficiency virus type 1 Vpr: functions and molecular interactions
J. Gen. Virol., August 1, 2009; 90(8): 1795 - 1805.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Poon, M. A. Chang, and I. S. Y. Chen
Vpr Is Required for Efficient Nef Expression from Unintegrated Human Immunodeficiency Virus Type 1 DNA
J. Virol., October 1, 2007; 81(19): 10515 - 10523.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Majumder, N. J. Venkatachari, E. A. Schafer, M. L. Janket, and V. Ayyavoo
Dendritic Cells Infected with vpr-Positive Human Immunodeficiency Virus Type 1 Induce CD8+ T-Cell Apoptosis via Upregulation of Tumor Necrosis Factor Alpha
J. Virol., July 15, 2007; 81(14): 7388 - 7399.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Varin, A.-Z. Decrion, E. Sabbah, V. Quivy, J. Sire, C. Van Lint, B. P. Roques, B. B. Aggarwal, and G. Herbein
Synthetic Vpr Protein Activates Activator Protein-1, c-Jun N-terminal Kinase, and NF-{kappa}B and Stimulates HIV-1 Transcription in Promonocytic Cells and Primary Macrophages
J. Biol. Chem., December 30, 2005; 280(52): 42557 - 42567.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Yoshizuka, Y. Yoshizuka-Chadani, V. Krishnan, and S. L. Zeichner
Human Immunodeficiency Virus Type 1 Vpr-Dependent Cell Cycle Arrest through a Mitogen-Activated Protein Kinase Signal Transduction Pathway
J. Virol., September 1, 2005; 79(17): 11366 - 11381.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Majumder, M. L. Janket, E. A. Schafer, K. Schaubert, X.-L. Huang, J. Kan-Mitchell, C. R. Rinaldo Jr., and V. Ayyavoo
Human Immunodeficiency Virus Type 1 Vpr Impairs Dendritic Cell Maturation and T-Cell Activation: Implications for Viral Immune Escape
J. Virol., July 1, 2005; 79(13): 7990 - 8003.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Iordanskiy, Y. Zhao, L. Dubrovsky, T. Iordanskaya, M. Chen, D. Liang, and M. Bukrinsky
Heat Shock Protein 70 Protects Cells from Cell Cycle Arrest and Apoptosis Induced by Human Immunodeficiency Virus Type 1 Viral Protein R
J. Virol., September 15, 2004; 78(18): 9697 - 9704.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Carlson, G. Leisman, J. Limoges, G. D. Pohlman, M. Horiba, J. Buescher, H. E. Gendelman, and T. Ikezu
Molecular Characterization of a Putative Antiretroviral Transcriptional Factor, OTK18
J. Immunol., January 1, 2004; 172(1): 381 - 391.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Hood, A. L. Cunningham, B. Slobedman, R. A. Boadle, and A. Abendroth
Varicella-Zoster Virus-Infected Human Sensory Neurons Are Resistant to Apoptosis, yet Human Foreskin Fibroblasts Are Susceptible: Evidence for a Cell-Type-Specific Apoptotic Response
J. Virol., December 1, 2003; 77(23): 12852 - 12864.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Zander, M. P. Sherman, U. Tessmer, K. Bruns, V. Wray, A. T. Prechtel, E. Schubert, P. Henklein, J. Luban, J. Neidleman, et al.
Cyclophilin A Interacts with HIV-1 Vpr and Is Required for Its Functional Expression
J. Biol. Chem., October 31, 2003; 278(44): 43202 - 43213.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Komoto, S. Tsuji, M. S. Ibrahim, Y.-G. Li, J. Warachit, K. Taniguchi, and K. Ikuta
The Vpu Protein of Human Immunodeficiency Virus Type 1 Plays a Protective Role against Virus-Induced Apoptosis in Primary CD4+ T Lymphocytes
J. Virol., October 1, 2003; 77(19): 10304 - 10313.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. P. Sherman, C. M. C. de Noronha, L. A. Eckstein, J. Hataye, P. Mundt, S. A. F. Williams, J. A. Neidleman, M. A. Goldsmith, and W. C. Greene
Nuclear Export of Vpr Is Required for Efficient Replication of Human Immunodeficiency Virus Type 1 in Tissue Macrophages
J. Virol., July 1, 2003; 77(13): 7582 - 7589.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Hay and G. Kannourakis
A time to kill: viral manipulation of the cell death program
J. Gen. Virol., June 1, 2002; 83(7): 1547 - 1564.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Arganaraz, M. J. Cortes, S. Leibel, and J. Lama
Human Immunodeficiency Virus Type 1 Vpr Protein Does Not Modulate Surface Expression of the CD4 Receptor
J. Virol., March 19, 2002; 76(8): 4125 - 4130.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. A. Eckstein, M. P. Sherman, M. L. Penn, P. S. Chin, C. M.C. De Noronha, W. C. Greene, and M. A. Goldsmith
HIV-1 Vpr Enhances Viral Burden by Facilitating Infection of Tissue Macrophages but Not Nondividing CD4+ T Cells
J. Exp. Med., November 12, 2001; 194(10): 1407 - 1419.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
O. Gjoerup, D. Zaveri, and T. M. Roberts
Induction of p53-Independent Apoptosis by Simian Virus 40 Small t Antigen
J. Virol., October 1, 2001; 75(19): 9142 - 9155.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. Basanez and J. Zimmerberg
HIV and Apoptosis: Death and the Mitochondrion
J. Exp. Med., February 19, 2001; 193(4): f11 - f14.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.